title: Bortezomib-induced inflammatory neuropathy.
authors.forename: Tabish A
authors.initials: TA
authors.lastname: Saifee
authors.forename: Kathryn J
authors.initials: KJ
authors.lastname: Elliott
authors.forename: Neil
authors.initials: N
authors.lastname: Rabin
authors.forename: Kwee L
authors.initials: KL
authors.lastname: Yong
authors.forename: Shirley
authors.initials: S
authors.lastname: D'Sa
authors.forename: Sebastian
authors.initials: S
authors.lastname: Brandner
authors.forename: Michael P
authors.initials: MP
authors.lastname: Lunn
authors.forename: Julian
authors.initials: J
authors.lastname: Blake
authors.forename: Mary M
authors.initials: MM
authors.lastname: Reilly
mesh_terms: D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D006801:Humans; D007249:Inflammation / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology; D018836:Inflammation Mediators / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D009431:Neural Conduction / Q000502:physiology; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology*; D011719:Pyrazines / Q000009:adverse effects*
chemical_list: D001897:Boronic Acids; D018836:Inflammation Mediators; D011719:Pyrazines; D000069286:Bortezomib